Home trial results must be due soon29 Mar 2021 12:36
Lots of news due soon
Below from RNS’ 20th January
“We are delighted to announce completion of recruitment into the SG016 Home trial. This is a remarkable trial evaluating a novel therapeutic delivered in the home setting to people with COVID-19 who are at risk of developing complications. We have shown that inhaled therapies can be safely delivered at home, without the need for the patients, nurses or doctors to travel. Following the promising results from the SG016 Hospital Study, we are excited to see whether we can detect important benefits from early use of inhaled interferon beta (SNG001) for COVID-19 in the home environment, in terms of resolution of symptoms, preventing hospitalisation, and reducing the burden of Long-COVID."